DNA Direct

By Turna Ray

Canada's Center of Excellence in Personalized Medicine last week launched a personalized medicine portal developed in collaboration with DNA Direct.

By Monica Heger
One major hurdle in bringing next-generation sequencing into the clinic is how it will be received by payors and hospitals.

Express Scripts is the only one out of the big three PBMs that hasn't yet made an acquisition to directly support a personalized medicine focus. However, the firm has expressed an interest in applying PGx strategies to rein in healthcare costs, and acquiring Medco would bring it such capabilities.

Roche and Clovis Oncology to develop PCR-based companion IVD for EGFR mutations; Medco Health to offer MolecularMD's qRT-PCR test for BCR-ABL.

The Medco subsidiary signed up a couple of health plans and hospitals to use its personalized medicine services.

The trial plans to study whether it is cost-effective to use a genetic test and CT scans to identify smokers at risk of getting lung cancer.

In launching Precision Health Solutions, Medco will expand access to pharmacogenetic tests to all its customers.

Pharmacy-benefits manager Medco this week outlined some activities planned for the Medco Research Institute, which is spearheading the company's pharmacogenomics research efforts. Additionally, during the company's 2009 earnings call, officials discussed the acquisition of DNA Direct and the forthcoming release of results from a study looking at PGx-guided warfarin dosing.

Medco's decision to buy DNA Direct signals its intent to be a "one-stop shop" for payors and employers interested in using genetically guided medicine to make healthcare more efficient and lower costs.

Pages

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.